|
SMNDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.790400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.110200E-01 |
| Normal-vs-Stage2 |
6.238800E-01 |
| Normal-vs-Stage3 |
1.986990E-01 |
| Normal-vs-Stage4 |
3.060400E-02 |
| Stage1-vs-Stage2 |
5.589800E-01 |
| Stage1-vs-Stage3 |
1.613970E-01 |
| Stage1-vs-Stage4 |
1.301660E-02 |
| Stage2-vs-Stage3 |
5.261000E-01 |
| Stage2-vs-Stage4 |
4.298000E-02 |
| Stage3-vs-Stage4 |
1.045840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.901200E-01 |
| Normal-vs-AfricanAmerican |
3.485000E-01 |
| Normal-vs-Asian |
4.437400E-01 |
| Caucasian-vs-AfricanAmerican |
3.097800E-01 |
| Caucasian-vs-Asian |
2.409600E-01 |
| AfricanAmerican-vs-Asian |
5.996400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.698400E-01 |
| Normal-vs-Female |
6.222300E-02 |
| Male-vs-Female |
1.599920E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.848800E-01 |
| Normal-vs-Extreme_Weight |
4.366200E-01 |
| Normal-vs-Obese |
4.590000E-01 |
| Normal-vs-Extreme_Obese |
9.982400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.824000E-01 |
| Normal_Weight-vs-Obese |
5.911000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.934800E-01 |
| Extreme_Weight-vs-Obese |
1.446450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.078600E-01 |
| Obese-vs-Extreme_Obese |
7.145800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.848100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.636180E-01 |
| Normal-vs-Age(61-80Yrs) |
3.712200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.402100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.015700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.415300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.356400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.320050E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.240200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.630600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.655200E-01 |
| Normal-VS-Type2 PRCC |
7.246400E-01 |
| Normal-VS-KIRP CIMP |
1.70880000005535E-06 |
| Normal-VS-Unclassified PRCC |
6.526600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.232200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.9823399999952E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.902000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.798300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.125000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.081840E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.022800E-01 |
| Normal-vs-N1 |
2.596000E-03 |
| Normal-vs-N2 |
8.449600E-01 |
| N0-vs-N1 |
2.17549999999012E-05 |
| N0-vs-N2 |
5.121000E-01 |
| N1-vs-N2 |
2.168000E-01 |
|
|
